Download the full-sized PDF
Permanent link (DOI): https://doi.org/10.7939/R3D53F
This file is in the following communities:
|Pharmacy and Pharmaceutical Sciences, Faculty of|
This file is in the following collections:
|Other Publications (Biological Sciences)|
THE RISK OF GETTING ANTI-TUBERCULOSIS DRUGS AS OVER THE COUNTER DRUGS Open Access
- Author or creator
EL‐Ghazouly, Karim M.
Deabis, Nehal M
- Additional contributors
- Type of item
- Conference/workshop Poster
November 14-18, 2011
often ineffective in controlling tuberculosis among patients who use illicit drugs1. The occurrence of multidrug-resistant tuberculosis is increasing in many parts of the world. Resistance of Mycobacterium tuberculosis (M. Tuberculosis) to Anti-tuberculosis drugs is man-made. In Egypt, private pharmacies constitute an important part of the private healthcare sector where some Anti-tuberculosis drugs dispensed without prescriptions. With such malpractice emergence of serious types of M. tuberculosis- resistant strains is highly likely to occur. Methods: Surveys of a random sample of 78 pharmacies in Alexandria and Behira for Anti-tuberculosis drugs were included in our study. These pharmacies were divided into hospital pharmacies, pharmacies in rural areas and pharmacies in urban areas. Questionnaires were given to these pharmacies, and interviews were carried out based on a structured questionnaire. Results: It was found that 90.8% of the pharmacies enrolled in this study hold in their inventoryAnti-tuberculosis drugs; however, 77% of them dispense these drugs without prescription, while 15.4% advice the patient about their risks. Nevertheless, 20% only ask the patient why they take these drugs Conclusion: Awareness to patient taking Anti-tuberculosis drugs about their risk is of paramount importance, meanwhile; awareness to pharmacists dispensing these drugs about their risk. Imposing a penalty on pharmacists dispensing Anti-tuberculosis drugs without prescription. Limiting the dispensing of these drugs to hospitals curing tuberculosis . encouraging pharmacists to counsel the patient asking for these drugs, are all viable options.
- Date created
- License information
- Creative Commons Attribution-Non-Commercial-No Derivatives 3.0 Unported
- Citation for previous publication
1- Oeltmann JE, Kammerer JS, Pevzner ES, Moonan PK. Tuberculosis and substance abuse in the United States, 1997-2006. Arch Intern Med. 2009;169(2):189-197
2- Thoen CO, Lobue PA, Enarson DA, Kaneene JB, de Kantor IN. Tuberculosis: A Re-Emerging Disease in Animals and Humans. Vet Ital; 2009; 45(1):135-81.
3- Böttger, E. C. and Springer, B. Mycobacterium tuberculosis: Drug Resistance and Genetic Mechanisms – Facts, Artifacts, and Fallacies, in AIDS and Tuberculosis: A Deadly Liaison (eds S. H. E. Kaufmann and B. D. Walker), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. (2009) ch 5.
4- Carvalho AC, Migliori GB, Cirillo DM. Tuberculosis in Europe: a problem of drug resistance or much more?. Expert Rev Respir Med 2010; 4(2) :189-200
- Link to related item
- Date Uploaded
- Date Modified
- Audit Status
- Audits have not yet been run on this file.
File format: pdf (Portable Document Format)
Mime type: application/pdf
File size: 110359
Last modified: 2015:10:12 10:35:49-06:00
Filename: My Poster ICIUM.pdf
Original checksum: 412cfa4385a4a08e71269d1ceb403ca0
Well formed: true
File title: THE RISK OF GETTING ANTI-TB DRUGS AS OTC DRUGS
File author: Karim El-Ghazouly
Page count: 1